CytomX Therapeutics
CTMX
CTMX
69 hedge funds and large institutions have $60.4M invested in CytomX Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Holders
69
Holding in Top 10
–
Calls
$143K
Puts
$10K
Top Buyers
| 1 | +$3.57M | |
| 2 | +$1.08M | |
| 3 | +$844K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$479K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$465K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$1.46M | |
| 3 | -$1.4M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$366K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$328K |